Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural Products.

Shenkar J, Griffiths JC

Open source

DOI
10.1002/cpt.1119
Published
2018 Sep
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.1119,
  title = {Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural Products.},
  author = {Shenkar J and Griffiths JC},
  year = {2018},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.1119},
  url = {https://doi.org/10.1002/cpt.1119}
}

RIS

TY  - JOUR
TI  - Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural Products.
AU  - Shenkar J
AU  - Griffiths JC
PY  - 2018
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.1119
UR  - https://doi.org/10.1002/cpt.1119
ER  - 

APA

J, S., & JC, G. (2018). Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural Products.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.1119

Source records